Driving commercial success for companies and patient groups dedicated to serving the rare disease community is the focus of the newly named Rarity Health, headquartered in Shrewsbury, New Jersey.
| SHREWSBURY, N.J., April 23, 2019 /PRNewswire/ -- Driving commercial success for companies and patient groups dedicated to serving the rare disease community is the focus of the newly named Rarity Health, headquartered in Shrewsbury, New Jersey. Known formerly as ENA Healthcare Communications, Rarity Health is introducing its new identity to demonstrate the strategic shift it has made toward meeting a clear unmet need in the U.S. and European marketing communications industry.
Drawing on its more than 34 years of experience in serving biotech and pharmaceutical companies in launching new products that treat rare diseases, the Rarity Health team brings deep knowledge of market conditioning, research and analysis, segmentation, medical key opinion leader development, strategic marketing and communication planning and execution, patient organization engagement, and more. Its proprietary service offering, Rarity Launchpad™, is the premiere, customizable product launch system designed to address the unique complexities of the rare disease therapeutics market. By applying an integrated approach, Rarity Launchpad develops a scientific communication strategy and engages all stakeholders while preparing the market for the launch of a novel therapy. “The number of new treatments for orphan and super-orphan therapies has been surging in recent years and will continue to do so as new and curative treatments promise the prospect of a better quality of life for patients with these conditions,” said Rarity Health Senior Managing Partner, Ted Newland. “Rare disease patient populations are small when compared to other areas of medicine. Having a deep understanding of how to market successfully in this highly dynamic arena, at each step of a brand’s life cycle, is imperative. Rarity Health brings the expertise and wisdom needed to accomplish exactly that.” “Our Rarity Launchpad has proven to be a critical component of several of our clients’ long-range commercial strategies,” said Rob Newland, Rarity Health Managing Partner. “Time is of the essence at each step in a product’s life cycle, from the clinical stage through to market launch and post-launch. We bring uncommon strategies and rare disease experience to create solid returns on every investment along the way. Rarity Launchpad provides a highly customizable launch system that takes the complexity out of rare disease product launches while anticipating and delivering on every client need.” Rarity Health designed Rarity Launchpad to meet the needs of patients, clinicians, and industry in the evolving rare disease pharmaceutical space. About Rare Disease About Rarity Health Drawing on more than 34 years of success in the rare disease space, Rarity Health has developed a highly customizable, brand-specific blueprint, Rarity Launchpad, for product launches. We leverage deep market insights, strategy, and science with dynamic creative execution, and innovative digital tactics to serve our clients in the biotech and pharmaceutical industries. From pre-launch to launch and re-launch, it’s rare—well done. Contact Media Contact:
SOURCE Rarity Health |
View original content to download multimedia:
